Patents by Inventor Yorgo Modis

Yorgo Modis has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Druggable regions in the dengue virus envelope glycoprotein and methods of using the same
    Patent number: 8673552
    Abstract: The present invention relates to novel druggable regions discovered in dengue virus envelope glycoprotein, or dengue virus E protein, which is a class II viral E protein. The present invention further relates to methods of using the druggable regions to screen potential candidate therapeutics for diseases caused by viruses having class II E proteins, e.g. viral fusion inhibitors.
    Type: Grant
    Filed: April 27, 2009
    Date of Patent: March 18, 2014
    Assignee: Children's Medical Center Corporation
    Inventors: Yorgo Modis, Stephen C. Harrison
  • Novel Druggable Regions in the Dengue Virus Envelope Glycoprotein and Methods of Using the Same
    Publication number: 20100105151
    Abstract: The present invention relates to novel druggable regions discovered in dengue virus envelope glycoprotein, or dengue virus E protein, which is a class II viral E protein. The present invention further relates to methods of using the druggable regions to screen potential candidate therapeutics for diseases caused by viruses having class II E proteins, e.g. viral fusion inhibitors.
    Type: Application
    Filed: April 27, 2009
    Publication date: April 29, 2010
    Applicant: Children's Medical Center Corporation
    Inventors: Yorgo Modis, Stephen C. Harrison
  • Druggable regions in the dengue virus envelope glycoprotein and methods of using the same
    Patent number: 7524624
    Abstract: The present invention relates to novel druggable regions discovered in dengue virus envelope glycoprotein, or dengue virus E protein, which is a class II viral E protein. The present invention further relates to methods of using the druggable regions to screen potential candidate therapeutics for diseases caused by viruses having class II E proteins, e.g. viral fusion inhibitors.
    Type: Grant
    Filed: October 24, 2005
    Date of Patent: April 28, 2009
    Assignee: Children's Medical Center Corporation
    Inventors: Yorgo Modis, Stephen C. Harrison
  • Novel druggable regions in the dengue virus envelope glycoprotein and methods of using the same
    Publication number: 20090035753
    Abstract: The present invention relates to novel druggable regions discovered in dengue virus envelope glycoprotein, or dengue virus E protein, which is a class II viral E protein. The present invention further relates to methods of using the druggable regions to screen potential candidate therapeutics for diseases caused by viruses having class II E proteins, e.g. viral fusion inhibitors.
    Type: Application
    Filed: October 24, 2005
    Publication date: February 5, 2009
    Inventors: Yorgo Modis, Stephen Harrison
  • Novel druggable regions in the dengue virus envelope glycoprotein and methods of using the same
    Publication number: 20060252052
    Abstract: The present invention relates to novel druggable regions discovered in dengue virus envelope glycoprotein, or dengue virus E protein, which is a class II viral E protein. The present invention further relates to methods of using the druggable regions to screen potential candidate therapeutics for diseases caused by viruses having class II E proteins, e.g. viral fusion inhibitors.
    Type: Application
    Filed: October 24, 2005
    Publication date: November 9, 2006
    Inventors: Yorgo Modis, Stephen Harrison